RANIA SHAMEKH
Physician at Melville Ave, Tampa, FL
License number
Florida 19281
Issued Date
Jun 13, 2013
Effective Date
Jun 13, 2013
Expiration Date
Jun 30, 2017
Category
Health Care
Type
Registration for Resident/HSE Physician
Address
Address
202 S Melville Ave, Tampa, FL 33606
Phone
(813) 731-2411
Professional information
Research Associate At Usf
Position:
Research Associate at USF
Location:
Tampa/St. Petersburg, Florida Area
Industry:
Research
Work:
USF
-
Research Associate
Rania Shamekh - Tampa, FL
Work:
Obesity, Diabetes, and Aging Research Center
Research Associate Anatomy and Cell Biology
Research Assistant Anatomy and Cell Biology
Research Assistant
Research Associate Anatomy and Cell Biology
Research Assistant Anatomy and Cell Biology
Research Assistant
Education:
Ain Shams University - Cairo
M.S Ain Shams University - Cairo
B.S
M.S Ain Shams University - Cairo
B.S
Skills:
Microsoft Office (Excel, Word, PowerPoint)
Stable Differentiation Of Adult Stem Cells
US Patent:
2008016, Jul 3, 2008
Filed:
Dec 28, 2007
Appl. No.:
11/966427
Inventors:
Samuel Saporta - Tampa FL, US
Elise Spencer - Tampa FL, US
Rania Shamekh - Tampa FL, US
Elise Spencer - Tampa FL, US
Rania Shamekh - Tampa FL, US
Assignee:
UNIVERSITY OF SOUTH FLORIDA - Tampa FL
International Classification:
C12N 5/02, C12N 5/00
US Classification:
435377, 435325
Abstract:
A method of differentiating adult stem cells, such as those derived from a teratocarcinoma cell line, the Ntera2/D1 clone (NT2). The developed cells exhibit a stable neurotransmitter phenotype without the required use of growth factors or retinoic acid in differentiation process, which may be difficult to completely remove during commercial production. An identification of specific neurotransmitters is possible in these differentiated NT2-derived neurons (NT2-N) after 30 days in culture or 30 days survival in vivo. The invention includes a method to stably differentiate neuronal stem/precursor cells to a neuronal phenotype for use in cell replacement therapy for neurodegenerative disease, stroke or spinal cord injury. At least four different types of neurons are produced from this method of differentiation: dopaminergic, cholinergic, GABAergic and glutaminergic. Additionally, since the cells are a cancer stem cell prior to differentiation, they may serve as a model system for developing anti-cancer therapies aimed at the cancer stem cell, rather than the more differentiated daughter cell.
Induction Of Immune Tolerance By Sertoli Cells
US Patent:
2007006, Mar 22, 2007
Filed:
Sep 20, 2006
Appl. No.:
11/524003
Inventors:
Don Cameron - Lutz FL, US
Nagwa Dajani - Seminole FL, US
Rania Shamekh - Tampa FL, US
Samuel Saporta - Tampa FL, US
Nagwa Dajani - Seminole FL, US
Rania Shamekh - Tampa FL, US
Samuel Saporta - Tampa FL, US
International Classification:
A61K 48/00
US Classification:
424093210, 424093700
Abstract:
The subject invention pertains to methods to enhance the therapeutic effects of cell therapy in various diseases and disorders. More particularly, the present invention provides methods of inducing systemic immune tolerance, thereby reducing or eliminating the need for systemic immunosuppression, by administering isolated Sertoli cells to an individual in need of treatment, wherein the isolated Sertoli cells are administered to the individual prior to or during administration of the therapy, e.g., cellular therapy.